At LARVOL, we believe a significant amount of public data exists that has not been expertly curated to document the link between biomarkers and cancer drug response.
The purpose and mission, in creating VERI, is to build the single most extensive, user-friendly, up-to-date database of the link between cancer biomarkers and a drug/MOA response, be it for sensitivity or resistance soon to be followed by toxicity.
Our core group of curators, many with PhD's and some MD's, curate information from various sources which include literature, conferences, clinical trials, regulatory and guideline documents. Curated data is verified with a calibrated level of evidence and presented in a unique and user-friendly way that is easy to search and analyze.